Endocrinology involves study of the endocrine system, responsible for secretion of hormones and maintaining its balance in the body. Fluctuation in hormone secretion causes endocrine disorders which are broadly categorised as hyposecretion, hypersecretion and tumors. Common endocrine disorders include diabetes mellitus, acromegaly, Addison’s disease, Cushing’s syndrome, Grave’s disease, Hashimoto’s thyroiditis, hyperthyroidism, hypothyroidism, Fabry disease, Gaucher's disease, growth hormone deficiency, hypercholesterolemia, hyperglycemia, hyperinsulinemia, hyperkalemia, hyperlipidemia, insulin resistance, lipodystrophy, obesity, gigantism, lipid disorder and others. Out of these, diabetes and thyroid diseases are the most common endocrine disorders globally.
Global endocrine drugs market is generally segmented into diabetes, growth hormone, acromegaly and hypogonadism. Of these, diabetes drug market captures majority of the market with the highest growth rate. Hypogonadism comprising testosterone, estrogen and progesterone replacement therapy is also expected to grow due to increasing awareness about postmenopausal and testosterone hazards. In addition, rising R&D activities, increased acceptability of new formulations and drug intake will propel overall endocrine drugs market growth.
On the other hand, high cost of treatment and R&D, complex reimbursement policies and limited awareness of disorders are the major hurdles in the growth of this market. In addition, patent expirations of endocrine drugs are expected to affect overall revenues of major companies.
Metabolism involves all chemical reactions essential to generate and consume energy for proper functioning of the body. Some indicators of metabolic syndrome are abdominal obesity, high fasting plasma glucose, elevated serum triglycerides, increased blood pressure and low levels of high-density lipoprotein (HDL).
Metabolic testing is equally crucial for proper diagnosis and treatment. Global metabolic testing market is segmented by product as CPET, body composition analysis, ECG and portable systems, and by technologies it can be segmented as VO2 max, RMR and REE analysis. Increasing incidence of lifestyle diseases, advancement in technology as well as growing healthcare expenditure are likely to be the major drivers of the market.
ASDReport.com has an extensive array of reports on endocrinology and metabolic syndrome. The reports provide insights on various topics and disorders like, osteopenia, dyslipidemia, prolactinoma, avitaminosis, invokana, mucopolysaccharidosis, gastric ulcers, and others.